I-Cefdinir CAS:91832-40-5
I-Cefdinir idla ngokumiselwa ukulwa nosulelo lweebhaktiriya olufana ne-pneumonia efunyanwa luluntu, ukuqina okukhulu kwe-bronchitis engapheliyo, i-sinusitis, i-otitis media, kunye nosulelo lwesikhumba kunye nezicubu ezithambileyo. Indlela yayo yomlomo inika ukuguquguquka kunye nokulula kwizigulana ezifuna unyango lwangaphandle lwezifo zebhaktiriya ezisengozini. Ababoneleli bezempilo bamisela idosi efanelekileyo, amaxesha, kunye nobude bonyango lwe-cefdinir ngokusekelwe kusulelo oluthile, i-pathogen echongiweyo, kunye nezinto eziqwalaselwe ngumguli ngamnye. Izigulana ziyacetyiswa ukuba zithathe i-cefdinir njengoko kuyalelwe kwaye zigqibe ikhosi epheleleyo yee-antibiotics, nokuba iimpawu ziyaphucuka ngaphambi kokuba amayeza agqitywe. Ukujonga rhoqo iziphumo ebezingalindelekanga, iimpendulo ze-allergy, kunye nokusebenza kakuhle konyango kubalulekile ngexesha lonyango lwe-cefdinir. Ukunamathela kwirejimeni yonyango emiselweyo kubalulekile ukuqinisekisa ukupheliswa kosulelo kunye nokuthintela uphuhliso lokuxhathisa ii-antibiotic. Ngokulandela ngokusondeleyo izikhokelo zokusetyenziswa ezicetyiswayo kunye neendlela ezilungileyo zokumisela nokusebenzisa i-cefdinir, iingcali zezempilo zijolise ekulawuleni ngempumelelo usulelo lweebhaktiriya ngelixa zinciphisa amathuba okuba kuvela iintlobo zeebhaktiriya ezinganyangekiyo. Intsebenziswano phakathi kwababoneleli bezempilo kunye nezigulana, kunye nokujonga ngononophelo kulo lonke unyango, kuxhasa ukusetyenziswa okukhuselekileyo nokusebenzayo kwe-cefdinir ekuzameni iziphumo ezilungileyo zeklinikhi kunye nokuphila kakuhle kwesigulana.
| Ukwakhiwa | C14H13N5O5S2 |
| Uvavanyo | 99% |
| Inkangeleko | umgubo omhlophe |
| Inombolo ye-CAS | 91832-40-5 |
| Ukupakisha | Encinci kwaye ininzi |
| Beka ubomi kwishelufa | iminyaka eyi-2 |
| Indawo yokugcina izinto | Gcina kwindawo epholileyo neyomileyo |
| Isiqinisekiso | I-ISO. |






![I-Ethyl N-[3-amino-4-(methylamino)benzoyl]-N-pyridin-2-yl-beta-alaninate CAS:212322-56-0](https://cdn.globalso.com/xindaobiotech/GRKLPVJ3QSJRM100.png)

